Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Guidance

Subcategories:Clinical Criteria/GuidelinesEthicsLegal UpdatesLegislation & AdvocacyMeeting ReportsResearch Rheum

Figure 2: High-resolution computed tomography showed evidence of interstitial lung disease.

High-resolution computed tomography shows evidence of ILD.

The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!

 

Dispelling the Mystery, Ensuring the Future

  |  

Bringing calm and organization to chaos: This is what led Greg Dennis, MD, to pursue a career in rheumatology. Dr. Dennis who, at the time, was an internal medicine resident at Fitzsimons Army Medical Center in Aurora, Colo., was seeking a subspecialty that would allow him to pursue immunology in a clinical or laboratory setting. What he realized during his residency was that rheumatology was a mystery to many physicians.

Rheumatology Professionals and Patient Advocates Take Their Stories to Capitol Hill

  |  

The ACR’s annual Advocates for Arthritis conference, September 19–20, brought more than 120 rheumatologists, rheumatology health professionals, and patient advocates to our nation’s capital. Attendees, representing 37 states, met with more than 175 congressional offices, sharing their stories of access to care, treatment, and the importance of research.

EULAR Magic

David S. Pisetsky, MD, PhD  |  

Colorful characters and old friends meet in London

REF: Looking at Recent Achievements and FInding Inspiration for the Future

E. William St.Clair, MD  |  

As the term of my presidency at the ACR Research and Education Foundation (REF) comes to an end, it’s a good time to reflect on the past two years. While it’s important to recognize the REF’s milestones and major achievements—and I will do that in a moment—great work is being done every day by rheumatologists, healthcare professionals, and investigators. It is their goal to improve the treatment and care of people impacted by rheumatic disease, and it’s our mission to provide them with the resources to support their efforts.

REF Volunteer Brings Passion for Communicating to New Program

  |  

When the ACR REF recently sent out a call for volunteers for the newly created From the Field speakers’ bureau, Alan W. Friedman, MD, responded right away. “It’s exactly what I’ve been doing all along,” he says. “I want to bring my enthusiasm for the cause to other people.”

Learn How the ACR is Advancing Rheumatology on Capitol Hill

  |  

While you are at the 2011 ACR/ARHP Annual Scientific Meeting learning about the latest advancements in rheumatologic care, stop by the Advocacy kiosk at the ACR Resource Center to discuss the latest developments in health policy. Currently, medicine is on the verge of great change with Congress discussing everything from physician payment reform to cuts to biomedical research and medical liability reform. The ACR advocates on behalf of the rheumatology profession and our patients and is actively pursuing the following issues: